|
|
||||||||
Departments of 1 Physiology and 2 Bioengineering, and 3 Institute for Environmental Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
| |
ABSTRACT |
|---|
|
|
|---|
It is hypothesized that carotid body chemosensory activity is coupled to neurosecretion. The purpose of this study was to examine whether there was a correspondence between carotid body tissue dopamine (DA) levels and neuronal discharge (ND) measured from the carotid sinus nerve of perfused cat carotid bodies and to characterize interaction between CO2 and O2 in these responses. ND and tissue DA were measured after changing from normoxic, normocapnic control bicarbonate buffer (PO2 >120 Torr, PCO2 25-30 Torr, pH ~ 7.4) to normoxic hypercapnia (PCO2 55-57 Torr, pH 7.1-7.2) or to hypoxic solutions (PO2 30-35 Torr) with normocapnia (PCO2 25-30 Torr, pH ~ 7.4) or hypocapnia (PCO2 10-15 Torr, pH 7.6-7.8). Similar temporal changes for ND and tissue DA were found for all of the stimuli, although there was a much different proportional relationship for normoxic hypercapnia. Both ND and DA increased above baseline values during flow interruption and normocapnic hypoxia, and both decreased below baseline values during hypoxic hypocapnia. In contrast, normoxic hypercapnia caused an initial increase in ND, from a baseline of 175 ± 12 (SE) to a peak of 593 ± 20 impulses/s within 4.6 ± 0.9 s, followed by adaptation, whereas ND declined to 423 ± 20 impulses/s after 1 min. Tissue DA initially increased from a baseline of 17.9 ± 1.2 µM to a peak of 23.2 ± 1.2 µM within 3.0 ± 0.7 s, then declined to 2.6 ± 1.0 µM. The substantial decrease in tissue DA during normoxic hypercapnia was not consistent with the parallel changes in DA with ND that were observed for hypoxic stimuli.
chemosensory discharge; dopamine release; dopamine microsensors; hypocapnia; hypercapnia; hypoxia; neurosecretion
| |
INTRODUCTION |
|---|
|
|
|---|
INTERACTION BETWEEN CO2 and O2 in carotid body (CB) chemosensory discharge is well known (10-12, 16, 19, 20, 28-30). Within limits, the steady-state response to PCO2 is linear at a given PO2 (20). During normoxia [arterial PO2 (PaO2) = 100 Torr], lowering arterial PCO2 (PaCO2) decreases chemosensory activity toward zero, and neuronal discharge (ND) increases linearly with hypercapnia. During hypoxia, PaCO2 has to be even lower to achieve the same chemosensory activity, and ND increases with hypercapnia at a greater rate than during normoxia. This relationship between ND response and CO2-O2 is known as stimulus interaction. One presumed mechanism of chemosensory discharge is that it depends on proportional secretion of an excitatory neurotransmitter. The amount of neurosecretion in response to the stimulus should then correspond to the change in ND. One putative neurotransmitter, dopamine (DA), is generally thought to be inhibitory (see Ref. 12 for review), although there is also evidence for an excitatory role (11). The purpose of this study was to examine the relationship between DA release and ND and to determine whether there was any interaction between CO2 and O2 by using electrochemical microsensors to measure tissue DA.
Electrochemical measurements have confirmed that glomus cells release DA with hypoxia. Using carbon-fiber microelectrodes, Ureña et al. (35) have shown that DA is released from cultured rabbit glomus cells in response to hypoxia. Montoro et al. (25) used carbon-fiber microelectrodes to monitor DA secretion from rabbit glomus cells while measuring intracellular Ca2+ concentration ([Ca2+]i) by fura 2 microfluorimetry. They found little change in [Ca2+]i and DA secretion until bath PO2 was reduced to ~50 Torr. With further reduction in PO2, [Ca2+]i abruptly rose, with a parallel increase in DA secretion. Findings from isolated glomus cells, however, do not provide any direct information on whether the subsequent neurotransmitter action of DA is excitatory or inhibitory or whether it is a neuromodulator of the chemosensory response.
There have been relatively few studies that used electrochemical techniques to follow the time course of DA changes in the tissue of intact CBs to investigate its putative role as a neurotransmitter or neuromodulator. Donnelly (6) and Doyle and Donnelly (8) found that, when rat CBs were superfused with hypoxic solution (PO2 <10 Torr for 3 min), there was an increase in chemosensory discharge with a slow increase in DA measured with 10-µm-diameter carbon-fiber microelectrodes. Using a smaller (~5-µm tip) DA microsensor in perfused cat CBs, Buerk et al. (4) found very rapid temporal responses and large increases in DA (average ~20 µM) during the development of hypoxia after flow interruption.
In the present study, we simultaneously measured chemosensory discharge and tissue DA in an in vitro perfused cat CB preparation by using the smaller DA microsensor. We confirmed that there was CO2-O2 stimulus interaction for steady-state ND responses, with similar temporal responses and proportional relationships between tissue DA and ND during flow interruption and during normocapnic and hypocapnic hypoxia. However, the tissue DA response to normoxic hypercapnia differed from the hypoxic responses. This suggests that hypercapnic excitation does not act through the same mechanism.
| |
METHODS |
|---|
|
|
|---|
DA-sensitive electrochemical sensors (DA microsensors) were fabricated from single-barrel, metal-filled, glass micropipettes, gold plated inside a shallow recess, as described by Buerk et al. (4). Typical DA microsensors were fabricated with tip diameters ranging from 3 to 10 µm and with recesses ranging from 3- to 10-µm deep, and the microsensors were dip coated in liquid Nafion polymer (Aldrich Chemical). Calibrations were made in deoxygenated phosphate buffer at 37°C in a recirculating system controlled by a pump. DA sensitivities were determined by adding precise amounts of a concentrated stock solution. Amperometric currents were measured with a picoammeter (Keithley Instruments, model 610C) at constant voltage (150 mV) relative to a Ag/AgCl reference and were digitized by computer at 2- to 5-Hz sampling rates with a low-pass filter (5-Hz cutoff). There can be minor contributions to the current from other catecholamines (CAs) (epinephrine, norepinephrine) which require higher oxidation potentials for amperometric measurements (4). At 150 mV, the sensitivity to DA is at least 10-fold higher than sensitivity to epinephrine or norepinephrine.
CBs were sequentially removed from cats anesthetized with pentobarbital sodium (initial dose, 35 mg/kg ip) for in vitro studies with the use of a perfusion-superfusion system (3, 4, 16, 19). A section of the carotid artery bifurcation with the intact CB was mounted in a temperature-regulated chamber. The carotid sinus nerve was isolated, placed on a platinum electrode, and lifted up into a layer of paraffin oil for bipolar ND recordings. ND signals were passed through a 60-Hz notch filter and electronic amplitude discriminator with impulses counted every second. An analog ND signal was also tape recorded. CBs were perfused with solutions from a constant-pressure (80 Torr), gravity-driven reservoir. Effluent from the preparation was removed from the perfusion chamber by continuous suction. The control perfusate was a modified Tyrode solution containing (in mM) 112 NaCl, 4.7 KCl, 2.2 CaCl2, 1.1 MgCl2, 22 sodium glutamate, 21.4 NaHCO3, 5.0 HEPES, and 5.0 glucose, with pH ~ 7.4 at 37°C, and equilibrated by bubbling with compressed gas containing 5% CO2 and 20% O2. DA microsensors were positioned into CB tissue by a motorized microdrive with 0.5-µm step resolution (World Precision Instruments, model PM-10). Simultaneous ND recordings and DA microsensor measurements were made during normoxic hypercapnia (20% O2, PCO2 55-57 Torr, pH 7.1-7.2) and for 2-3 min during hypoxia (5% O2), with either normocapnia (PCO2 40 Torr, pH 7.4) or hypocapnia (PCO2 10-15 Torr, pH 7.6-7.8). The PO2, PCO2, and pH levels in different perfusates were checked on a blood-gas analyzer (Radiometer). Tissue DA and ND responses for each experimental maneuver were compared with respective baseline values during control perfusion with normoxic normocapnic bicarbonate buffer.
In seven experiments, simultaneous measurements of ND, tissue DA, and
tissue PO2 were made by using two
single-barrel microsensors. Recessed gold microelectrodes (36)
polarized at
0.7 V were used to measure tissue
PO2. Experimental details for tissue
PO2 measurements are described by Buerk et al. (3). Tape-recorded signals were digitized by computer (either 2- or 5-Hz sampling rates, 12-bit resolution) for subsequent data analysis.
Both ND and DA responses to hypercapnia were fit to a single exponential decay
|
) estimated by nonlinear least squares regression
(Sigmaplot, Jandel). The half-life [time for 50% change
(t50%) in ND
or DA] was calculated from
t50% = 
loge(0.5).
The mean time course for each type of stimulus was determined by averaging repeated trials for each experiment. Statistical comparisons were made by ANOVA (SigmaStat, Jandel) by using equal weighting for mean responses from each experiment, and P < 0.05 was considered as significant.
| |
RESULTS |
|---|
|
|
|---|
Effects of hypercapnia.
Induction of hypercapnia
(PCO2 = 55-57 Torr)
from normocapnic (PCO2 = 25-30
Torr) perfusate with the same PO2
(>120 Torr) caused a rapid increase in chemosensory discharge. A
total of 80 measurements were made in 13 cat CBs, with repeated trials
ranging between three and eight hypercapnic stimuli per experiment.
Average values were determined every 0.5 s, and equal weighting was
used for each experiment. Figure
1 A
shows the resulting values (means ± SE) for ND
(top) and tissue DA
(bottom) before and after switching
from normocapnic to hypercapnic perfusion at
t = 0. Hypercapnia caused an increase
in ND (
) from a baseline of 175 ± 12 impulses/s to a peak value
of 593 ± 20 impulses/s (P < 0.05, ANOVA) within 4.6 ± 0.9 s. Chemosensory activity declined to
~59% of the peak ND response and then to a final steady-state value
of 423 ± 20 impulses/s. The amount of adaptation (difference
between peak and steady-state ND) was 170 ± 20 impulses/s. Baseline
tissue DA (
) averaged 17.9 ± 1.1 µM (range 10-25 µM).
Hypercapnia caused an initial increase in tissue DA to a peak value of
23.2 ± 1.2 µM (P < 0.05)
within 3.0 ± 0.7 s. The time to reach peak tissue DA was not
significantly different from the time to reach peak ND. Tissue DA then
declined to 2.6 ± 1.0 µM, which was significantly below baseline
(P < 0.05). The decrease in tissue
DA to steady-state levels below baseline was seen in all 13 experiments.
|
,
left scale) and tissue DA (
,
right scale) during adaptation to
hypercapnia are shown in Fig. 1B by
overlaying the two responses with proportional scaling. Data points are
shown for every 0.5 s. After reaching peak values, both ND and tissue
DA declined exponentially. The average
for the decrease in ND was
14.1 ± 3.1 s
(t50% = 9.7 s).
Tissue DA fell from the peak value with a slightly faster average
of 9.0 ± 1.2 s
(t50% = 6.2 s).
However, there was no significant difference between the two time constants.
In experiments in which tissue PO2
was also measured, changes in PO2
with hypercapnia were variable, increasing in some experiments,
decreasing in others, and with essentially no change in many cases.
Overall, there was no significant change in tissue
PO2 during hypercapnia compared with
control (68.5 ± 5.2 vs. 70.6 ± 5.3 Torr,
respectively; 27 measurements in 7 CBs, 3-8 repeated trials per experiment).
Effect of normocapnic hypoxia.
When the CB was perfused with hypoxic bicarbonate buffer
(PO2 = 30-36 Torr) with
normocapnia (PCO2 = 25-30 Torr),
there was a rapid increase in chemosensory activity, as observed in
earlier experiments (4). As shown in Fig.
2 A, responses from one CB experiment (average of 8 measurements) show the
increases in ND (top) and tissue DA
(bottom) during normocapnic hypoxia.
The average control baseline tissue DA (dashed lines, bottom) was ~25 µM for this CB
and increased to ~37 µM with normocapnic hypoxia. In Fig.
2B, the similar time courses for the
rise in tissue DA (
, scale on
right) and ND (
, scale on
left) during normocapnic hypoxia are
shown by overlaying the two responses. Data were sampled at 5 Hz in
this example, allowing points every 0.2 s to be illustrated.
|
Effect of hypocapnic hypoxia.
When the CB was perfused with hypoxic bicarbonate buffer
(PO2 = 30-36 Torr) with
hypocapnia (PCO2 = 10-13 Torr),
there was a rapid decrease in chemosensory activity, which remained
depressed during the entire period of perfusion. Results from one CB
experiment (average of 5 trials) are shown in Fig. 3A,
indicating a decrease in ND (top),
with a parallel drop in tissue DA from ~14 to ~5 µM
(bottom), with the final
steady-state value below baseline. In Fig.
3B, the similar time courses for the
fall in ND (
, scale at left) and
tissue DA (
, scale at right) are
shown by the overlay of the data for every 0.5-s interval.
|
Effect of flow interruption.
The largest ND response and increase in tissue DA were observed after
stopping perfusion, as observed in earlier experiments (4). Figure
4 A
illustrates simultaneous changes in ND
(top), tissue DA
(middle), and
PO2
(bottom) after interrupting flow at
t = 0. The initial rate of
PO2 disappearance was
3.1 Torr/s (dashed line,
bottom). After 35 s, tissue
PO2 fell to near zero, and the
maximal ND was reached. Tissue DA (middle) began to
rise immediately after interruption of flow in parallel with the
increase in ND (top). In this
example, the rise in tissue DA was 0.8 µM/s, and the final value
reached a maximum ~36 µM, which was 22 µM above the control
baseline. In Fig. 4 B, the time courses for ND (
, scale to left)
and tissue DA (
, scale to right) are overlaid with data points every 0.5 s, clearly illustrating that
the rise in DA preceded the rise in ND at this location.
|
Interactions with CO2.
In Fig.
5 A,
values (means ± SE) for ND (top)
and DA (bottom) are plotted with
respect to the perfusate PCO2 for the
two hypoxic conditions (left) along
with the baseline, peak, and steady-state values for the normoxic
hypercapnic responses (right). The
stimulus interaction with PCO2 for
hypoxia (ND/PCO2 slope) was 27.5 impulses · s
1 · Torr
1
(solid line, top left). The peak
ND/PCO2 slope for normoxic hypercapnia was 13.1 impulses · s
1 · Torr
1
(dotted-dashed line, top right), and
decreased to 7.6 · s
1 · Torr
1
(solid line, top right) at steady
state. The peak ND/PCO2 slope was 1.7 times higher than the steady-state slope after adaptation. The
DA/PCO2 slope was positive for
hypoxia (1.58 µM/Torr; solid line,
bottom). The peak
DA/PCO2 slope for normoxic hypercapnia was also positive, but much smaller (0.17 µM/Torr, dotted-dashed line, bottom), and the
final slope after adaptation was negative (
0.5 µM/Torr; solid
line, bottom).
|
1 · s
1,
as shown in Fig.
5 B (dotted-dashed
line). The relationship between DA and ND was lower for hypocapnic
hypoxia (
), because both decreased from their respective control
baseline levels with low PCO2. The
relationship between DA and ND for the peak response to normoxic
hypercapnia (
) fell a little below the normocapnic hypoxia
relationship (dotted-dashed line). This is equivalent to ~7 µM less
than the level of DA that would be predicted for the same increase in
ND during hypoxia. After reaching steady state, the relationship
between DA and ND for normoxic hypercapnia (lower
) was ~22 µM
less than for the same increase in ND based on the hypoxic
relationship. Both peak and steady-state relationships reflect lower
tissue DA levels during normocapnic hypercapnia than would be expected
from the relationship between ND and DA found for the hypoxic responses.
| |
DISCUSSION |
|---|
|
|
|---|
In all four experimental maneuvers, there were similar temporal changes in tissue DA and ND. Whenever ND increased, tissue DA increased and vice versa. However, there were differences in proportional relationships between ND and tissue DA, as shown in Fig. 5B. The highest ND and tissue DA level occurred during flow interruption, presumably due to the severe hypoxic conditions (near zero PO2). Although there will be some increase in tissue PCO2 during flow interruption, we believe that this has a minor effect. Less severe hypoxia, during perfusion with 5% O2, caused an intermediate increase in ND and tissue DA. The lowest ND and DA were measured during hypocapnic hypoxia. This is consistent with CO2-O2 stimulus interaction reported earlier from in vivo cat CB studies by Lahiri et al. (20), in which chemosensory activity decreased as PaCO2 was reduced. The reduction in chemosensory activity under hypocapnic conditions inhibits ventilation, as shown by Smith et al. (31) in studies in awake dogs in which respiratory control feedback was altered by denervating one CB and perfusing the second, vascularly isolated CB with hypoxic saline and blood solutions with either normocapnic or hypocapnic conditions.
Steady-state responses to normoxic hypercapnia differed from the other stimuli; this suggests that the mechanism of hypercapnic excitation could be different from hypoxic mechanisms. We did observe an initial increase in DA during the peak ND response to hypercapnia, although the increase was less than might be expected if DA were proportional to the ND response. However, tissue DA then decreased substantially below baseline during adaptation of the ND response, even though chemosensory activity remained elevated above baseline after reaching steady state. This change in tissue DA was opposite to that found for the other responses, in which relative changes in tissue DA were proportional to the relative changes in ND.
We recently reported that carbon monoxide (CO) and CO2 demonstrate stimulus interaction (28). Because CO binds with cytochrome oxidase, the interaction with CO2 may provide additional evidence that cytochrome oxidase is the primary O2 sensor in hypoxic chemoreception. These observations, including results with hypoxic stimuli in the present study, might be interpreted as being consistent with the hypothesis that DA is an excitatory neurotransmitter, because DA release and chemosensory excitation are congruent. This is also consistent with our previous finding that DA increases rapidly during flow interruption (4). González-Guerrero et al. (13) have presented evidence in favor of an excitatory role for DA (also see Refs. 10-12).
However, there is overwhelming evidence that exogenous DA administration inhibits excitatory discharge, as first observed by Zapata (37). Furthermore, blocking D2 receptors can be excitatory. Lahiri et al. (21) found augmented hypoxic excitation after blocking DA receptors, and Iturriaga et al. (17) found that intravenous domperidone (an antagonist of D2 receptors) enhanced hypoxic responses. However, in another domperidone study, Tomares et al. (34) reported an increase in chemosensory activity in adult cats, but the researchers saw no noticeable effect on hypoxic sensitivity. There were much larger effects in neonatal cats. Dual effects were seen in an earlier study in our laboratory (26) with a perfused cat CB preparation. Morelli et al. (26) reported that bolus injections of DA initially caused ND inhibition, followed by a transient period of ND excitation. The DA antagonist haloperidol abolished ND responses to the DA bolus, as well as abolishing the ND responses to cyanide, nicotine, flow interruption, and hypercapnia. Responses to these stimuli fully recovered after CBs were returned to perfusate without haloperidol. The excitatory response to the DA bolus also returned, but the inhibitory response did not recover. The response to hypercapnia, as found in the present study, could be consistent with an inhibitory role for DA, if the marked decrease in tissue DA at steady state removed the inhibition and allowed much greater chemosensory activity.
There is also evidence that DA is unrelated to chemosensory activity.
In a recent rat CB study, Donnelly (5) reported that reserpine caused a
reduction in CA secretion with hypoxia. This was expected, because of
depletion of CAs, as confirmed from measurements with carbon-fiber
microelectrodes. However, reserpine had little or no effect on hypoxic
responses. Sun and Reis (32) concluded that DA is not essential for
hypoxic chemotransduction, since hypoxic responses, responses to
cyanide, and injections of tyramine to stimulate DA release from rat CB
in vivo were unchanged after systemic delivery of chlorpromazine, an
antagonist of DA receptors and
-adrenoreceptors. Iturriaga et al.
(15) reported that there was some correlation between CA
release and excitatory stimuli. However, they found that CA release was
progressively diminished with repeated flow interruptions, whereas ND
responses were unchanged. Also, exogenous application of DA did not
change hypoxic ND responses. They concluded that CA release is not
essential for hypoxic chemoreception. More recently, Iturriaga and
Alcayaga (14) measured CA release [reported as efflux or change
in CA (
CA)] from superfused cat CBs during hypoxia with and
without hypercapnia. They reported that hypercapnia, although evoking
chemosensory excitation, did not consistently increase
CA. Neither
the baseline CA nor the
CA with hypercapnia was reported. They also
observed that repeated hypoxic and hypercapnic challenges caused a
progressive decrease in
CA, whereas the ND remained essentially the
same. Their largest mean increase in
CA with the first hypoxic
challenge was smaller (2.9 ± 0.9 µM) than we found in the present
study (8.3 ± 1.0 µM above control). We did not observe any
systematic decline in tissue DA responses with repeated stimuli. The
most recent study by Iturriaga and Alcayaga (14) also concludes that DA
release is not essential for chemosensory excitation.
In our view, interpretations based on the time course of CA release from CBs measured with carbon-fiber microelectrodes remains problematic, especially when compared with the rapid temporal changes in tissue DA measured with shallow, recessed DA microsensors for all of the different stimuli reported in the present study. We have found differences between time courses for measurements with the two electrodes that were described previously (4). CA measurements in the CB with carbon-fiber microelectrodes (5, 6, 14, 17) tend to be much slower and considerably delayed compared with the chemosensory responses. Perhaps local damage with the larger sensors might be a confounding factor, or perhaps there are different reactions to the stimuli applied to superfused CBs compared with perfused CBs.
Our measurements of increased DA during hypoxia are consistent with results from hypoxic rat CBs by Donnelly (6), and in agreement with measurements of DA release from single glomus cells (25, 35), as well as studies that used radiolabeling techniques (10-12). Similarly, the rise in glomus cell [Ca2+]i (2, 23) due to hypoxia supports the concept that hypoxia depolarizes the cells, followed by influx of Ca2+ through voltage-gated Ca2+ channels. The role of ion channels in hypoxic chemoreception has been reviewed by López-Barneo (23). The proposed mechanism is that Ca2+ channels are normally inhibited until the K+ conductance is reduced by low PO2 (24). This initiates a burst of action potentials, lowering glomus cell membrane potential, removing inhibition of Ca2+ channels, and thus allowing Ca2+ to enter the cell. The elevation in [Ca2+]i leads to release of CA. The similarity between O2-dependent Ca2+ influx, CA secretion, and sensory activity was pointed out by López-Barneo (23). Although this idea is still a tentative hypothesis, it is supported by the fact that both DA release and chemosensory discharge are inhibited by decreased [Ca2+]i. Also, Bay K 8644 (a dihydropyridine which increases [Ca2+]i) triples the DA release with hypoxia in the presence of normal Ca2+ (11). We have shown (22) that thapsigargin, which releases Ca2+ from intracellular stores, can partially restore chemosensory activity during flow interruption after CBs have been perfused with zero-Ca2+ solutions.
A rise in
[Ca2+]i
is known to be associated with neurosecretion and sensory discharge.
Hypercapnia produces immediate intracellular acidosis and a rise in
[Ca2+]i
(1), which is consistent with the transient increase in DA that we
measured immediately after the hypercapnic stimulus. But with time and
in the presence of
CO2-HCO
3, H+ is extruded by the
Na+-dependent
Cl
/HCO
3
exchanger, thereby decreasing
[Ca2+]i
and neurosecretion. This decrease in
[Ca2+]i
may explain the time course of ND adaptation and decrease in DA that we
observed with normoxic hypercapnia. The influence of HCO
3 in the perfusate on intracellular
pH (pHi) through differential
effects on acid extrusion has been discussed by Thomas (33) with regard
to a study by Ganz et al. (9). Another possibility is that, under
acidic conditions, Ca2+ becomes
bound, thereby decreasing
[Ca2+]i,
as observed by Donnelly and Kholwadwala (7).
Radiolabeling studies by Rigual et al. (29) and Rocher et al. (30) found that a 5-min period of more severe hypercapnia (20% CO2) caused a much smaller increase in cumulative DA release compared with hypoxia. It is possible that the small efflux of DA that they measured might reflect a transient period of DA release similar to that observed in the present study with a more modest degree of hypercapnia. Using time-resolved electrochemical measurements of tissue DA, we found that the time courses for the decline in ND and tissue DA during adaptation were nearly identical, as shown in Fig. 1B, but that steady-state sensory discharge remained high despite the decrease in DA. Why ND remains elevated is an interesting question. A conventional explanation is that intracellular H+ (and pHi) is responsible for the excitation. However, Iturriaga et al. (18) have shown, using a pHi dye in the intact perfused cat CB, that hypoxic perfusion or short periods of flow interruption do not cause significant changes in pHi. Lahiri et al. (19) suggested that the initial ND response to hypercapnia is due to rapid, transient intracellular acidification, which initially exceeds the final steady-state change in pHi. The peak and adaptation of the ND response could be eliminated by inhibiting carbonic anhydrase. Active pHi regulation is the most likely explanation for the adaptation of the ND response with hypercapnia. Another possibility is that ionic changes with hypercapnic stimuli alter the sensitivity of D2 receptors. Neve (27) has shown that the conformation of D2 receptors in the brain is regulated by both pH and Na+.
Another factor could be increased washout, if there were appreciable vasodilation during hypercapnia. Vascular effects that cause changes in flow could complicate interpretations of experimental tissue DA measurements. A generalized mathematical expression for the time rate of DA change in perfused tissue might be
|
|
In summary, stimulus interaction with CO2 was observed with ND, but this interaction did not appear to be tightly coupled with DA neurosecretion. Responses of ND and DA release during hypoxia could be interpreted as being consistent with DA playing a role as an excitatory neurotransmitter since the phenomena were concomitant. However, an inhibitory role for DA might explain the high chemosensory activity during hypercapnia, since DA decreased to very low levels. Further experimental work is needed to elucidate the role of DA in chemosensory transduction.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grants HL-50180-03 and HL-43413-08.
| |
FOOTNOTES |
|---|
Address for reprint requests: D. G. Buerk, Depts. of Physiology and Bioengineering, and the Institute for Environmental Medicine, Univ. of Pennsylvania School of Medicine, 1 John Morgan Bldg., Philadelphia, PA 19104-6068.
Received 24 March 1997; accepted in final form 1 July 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Buckler, T. J.,
and
R. D. Vaughan-Jones.
Effects of hypercapnia on membrane potential and intracellular calcium in rat carotid body type I cells.
J. Physiol. (Lond.)
478:
157-171,
1994[Medline].
2.
Buckler, T. J.,
and
R. D. Vaughan-Jones.
Effects of hypoxia on membrane potential and intracellular calcium in rat neonatal carotid body type I cells.
J. Physiol. (Lond.)
476:
423-428,
1994
3.
Buerk, D. G.,
R. Itturiaga,
and
S. Lahiri.
Testing the metabolic hypothesis of O2 chemoreception in the cat carotid body in vitro.
J. Appl. Physiol.
76:
1317-1323,
1994
4.
Buerk, D. G.,
S. Lahiri,
D. Chugh,
and
A. Mokashi.
Electrochemical detection of rapid dopamine release kinetics during hypoxia in perfused/superfused cat carotid bodies.
J. Appl. Physiol.
78:
830-837,
1995
5.
Donnelly, D. F.
Chemoreceptor nerve activity may not be proportional to catecholamine secretion in rat carotid body.
J. Appl. Physiol.
81:
657-664,
1996
6.
Donnelly, D. F.
Electrochemical detection of catecholamine release from rat carotid body, in vitro.
J. Appl. Physiol.
74:
2330-2337,
1993
7.
Donnelly, D. F.,
and
D. Kholwadwala.
Hypoxia decreases intracellular calcium in adult rat carotid body glomus cells.
J. Neurophysiol.
67:
1543-1551,
1992
8.
Doyle, T. P.,
and
D. F. Donnelly.
Effect of Na+ and K+ channel blockade on hypoxia-induced catecholamine release from rat carotid body in vitro.
J. Appl. Physiol.
77:
2606-2611,
1994
9.
Ganz, M. B.,
G. Boyarsky,
R. B. Sterzel,
and
W. F. Boron.
Arginine vasopression enhances pHi regulation in the presence of HCO
3 by stimulating three acid-base transport systems.
Nature
337:
648-651,
1989[Medline].
10.
González, C.,
L. Almaraz,
A. Obeso,
and
R. Rigual.
Carotid body chemoreceptors: from natural stimuli to sensory discharges.
Physiol. Rev.
74:
829-898,
1994
11.
González, C.,
L. Almaraz,
A. Obeso,
and
R. Rigual.
Oxygen and acid chemoreception in the carotid body chemoreceptors.
Trends Neurosci.
15:
146-153,
1992[Medline].
12.
González, C.,
B. G. Dinger,
and
S. J. Fidone.
Mechanisms of carotid body chemoreception.
In: Regulation of Breathing (2nd ed.), edited by C. Lenfant,
J. A. Dempsey,
and A. I. Pack. New York: Dekker, 1995, vol. 79, p. 391-471. (Lung Biol. Health Dis. Ser.)
13.
González-Guerrero, P. R.,
R. Rigual,
and
C. González.
Effects of chronic hypoxia on opioid peptide and catecholamine levels and on the release of dopamine in the rabbit carotid body.
J. Neurochem.
60:
1769-1776,
1993[Medline].
14.
Iturriaga, R.,
and
J. Alcayaga.
Effects of CO2-HCO
3 on catecholamine efflux from cat carotid body.
J. Appl. Physiol.
84:
60-68,
1998
15.
Iturriaga, R.,
J. Alcayaga,
and
P. Zapata.
Dissociation of hypoxia-induced chemosensory responses and catecholamine efflux in cat carotid body superfused in vitro.
J. Physiol. (Lond.)
497:
551-564,
1996.
16.
Iturriaga, R.,
and
S. Lahiri.
Carotid body chemoreception in the absence and presence of CO2-HCO
3.
Brain Res.
568:
253-260,
1991[Medline].
17.
Iturriaga, R.,
C. Larrain,
and
P. Zapata.
Effects of dopaminergic blockade upon carotid chemosensory activity and its hypoxia-induced excitation.
Brain Res.
663:
145-154,
1994[Medline].
18.
Iturriaga, R.,
W. L. Rumsey,
S. Lahiri,
D. Spergel,
and
D. F. Wilson.
Intracellular pH and oxygen chemoreception in the cat carotid body in vitro.
J. Appl. Physiol.
12:
2259-2266,
1992.
19.
Lahiri, S.,
R. Iturriaga,
A. Mokashi,
F. Botré,
D. Chugh,
and
S. Osanai.
Adaptation to hypercapnia vs. intracellular pH in cat carotid body: responses in vitro.
J. Appl. Physiol.
80:
1090-1099,
1996
20.
Lahiri, S.,
A. Mokashi,
R. G. Delaney,
and
A. P. Fishman.
Arterial PO2 and PCO2 stimulus threshold for carotid chemoreceptors and breathing.
Respir. Physiol.
34:
359-375,
1978[Medline].
21.
Lahiri, S.,
T. Nishino,
A. Mokashi,
and
E. Mulligan.
Interaction of dopamine and haloperidol with O2 and CO2 chemoreception in carotid body.
J. Appl. Physiol.
49:
45-51,
1980
22.
Lahiri, S.,
S. Osanai,
D. G. Buerk,
A. Mokashi,
and
D. K. Chugh.
Thapsagargin enhances carotid body chemosensory discharge in response to hypoxia in zero [Ca2+]e: evidence for intracellular Ca2+ release.
Brain Res.
709:
141-144,
1996[Medline].
23.
López-Barneo, J.
Oxygen-sensing ion channels and the regulation of cellular functions.
Trends Neurosci.
19:
435-440,
1996[Medline].
24.
López-Barneo, J.,
J. López-López,
J. Ureña,
and
C. González.
Chemotransduction in the carotid body: K+ current modulated by PO2 in type I chemoreceptor cells.
Science
241:
580-582,
1988
25.
Montoro, R. J.,
J. Ureña,
F. Fernández-Chacón,
G. Alvarez de Toledo,
and
J. López-Barneo.
Oxygen sensing by ion channels and chemotransduction in single glomus cells.
J. Gen. Physiol.
107:
133-143,
1996
26.
Morelli, L.,
R. Iturriaga,
D. Spergel,
and
P. G. Data.
Effects of haloperidol on cat carotid body chemoreception in vitro.
In: Neurobiology and Cell Physiology of Chemoreception, edited by P. G. Data,
H. Acker,
and S. Lahiri. New York: Plenum, 1993, p. 295-299.
27.
Neve, K. A.
Regulation of dopamine D2 receptors by sodium and pH.
Mol. Pharmacol.
39:
570-578,
1991[Abstract].
28.
Osanai, S.,
D. K. Chugh,
A. Mokashi,
and
S. Lahiri.
Stimulus interaction between CO and CO2 in the cat carotid body chemoreception.
Brain Res.
711:
56-63,
1996[Medline].
29.
Rigual, R.,
J. R. López-López,
and
C. González.
Release of dopamine and chemoreceptor discharge induced by low pH and high PCO2 stimulation of the cat carotid body.
J. Physiol. (Lond.)
433:
519-531,
1991
30.
Rocher, A.,
A. Obeso,
C. González,
and
B. Herreros.
Ionic mechanisms for the transduction of acidic stimuli in rabbit carotid body glomus cells.
J. Physiol. (Lond.)
433:
533-548,
1991
31.
Smith, C. A.,
C. A. Harms,
K. S. Henderson,
and
J. A. Dempsey.
Ventilatory effects of specific carotid body hypocapnia and hypoxia in awake dogs.
J. Appl. Physiol.
82:
797-818,
1997.
32.
Sun, M.-K.,
and
D. J. Reis.
Dopamine or transmitter release from rat carotid body may not be essential to hypoxic chemoreception.
Am. J. Physiol.
267 (Regulatory Integrative Comp. Physiol. 36):
R1632-R1639,
1994
33.
Thomas, R. C.
Bicarbonate and pHi response.
Nature
337:
601,
1989[Medline].
34.
Tomares, S. M.,
O. S. Bamford,
L. M. Sterni,
R. S. Fitzgerald,
and
J. L. Carroll.
Effects of domperidone on neonatal and adult carotid chemoreceptors in the cat.
J. Appl. Physiol.
77:
1274-1280,
1994
35.
Ureña, J.,
R. Fernández-Chacón,
A. R. Benot,
G. Alvarez de Toledo,
and
J. López-Barneo.
Hypoxia induces voltage-dependent Ca2+ entry and quantal dopamine secretion in carotid body glomus cells.
Proc. Natl. Acad. Sci. USA
91:
10208-10211,
1994
36.
Whalen, W. J.,
J. Riley,
and
P. Nair.
A microelectrode for measuring intracellular PO2.
J. Appl. Physiol.
23:
798-801,
1967
37.
Zapata, P.
Effects of dopamine on carotid chemo- and baroreceptors in vitro.
J. Physiol. (Lond.)
244:
235-251,
1975
This article has been cited by other articles:
![]() |
M. Zhang and C. A. Nurse CO2/pH Chemosensory Signaling in Co-Cultures of Rat Carotid Body Receptors and Petrosal Neurons: Role of ATP and ACh J Neurophysiol, December 1, 2004; 92(6): 3433 - 3445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Joris, N. J. Poth, A. M. Djamadar, D. I. Sessler, E. E. Hamoir, T. R. Defechereux, M. R. Meurisse, and M. L. Lamy Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy{dagger} Br. J. Anaesth., December 1, 2003; 91(6): 857 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hanaoka, Y. Droma, J. Hotta, Y. Matsuzawa, T. Kobayashi, K. Kubo, and M. Ota Polymorphisms of the Tyrosine Hydroxylase Gene in Subjects Susceptible to High-Altitude Pulmonary Edema Chest, January 1, 2003; 123(1): 54 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Goll, O. Akca, R. Greif, H. Freitag, C. F. Arkilic, T. Scheck, A. Zoeggeler, A. Kurz, G. Krieger, R. Lenhardt, et al. Ondansetron is no More Effective than Supplemental Intraoperative Oxygen for Prevention of Postoperative Nausea and Vomiting Anesth. Analg., January 1, 2001; 92(1): 112 - 117. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |